An everolimus-eluting stent versus a paclitaxel-eluting stent in small vessel coronary artery disease: A pooled analysis from the SPIRIT II and SPIRIT III trials-Reference-Cited by-同舟云学术

An everolimus-eluting stent versus a paclitaxel-eluting stent in small vessel coronary artery disease: A pooled analysis from the SPIRIT II and SPIRIT III trials

Published:2010-01-25 Issue:1 Volume:76 Page:60-66
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet. Cardiovasc. Intervent.

Author:

Bartorelli Antonio L.,Serruys Patrick W.,Miquel-Hébert Karine,Yu Shui,Pierson Wes,Stone Gregg W.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ccd.22452/fullpdf

Reference24 articles.

1. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents;Kastrati;Circulation,2006

2. One-year clinical outcome after coronary stenting of very small vessels using 2.25 mm sirolimus- and pacliataxel-eluting stents: A comparison between RESEARCH and T-SEARCH registries;Rodriguez-Granillo;J Invasive Cardiol,2005

3. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery;Moses;N Engl J Med,2003

4. Oral everolimus inhibits in-stent neointimal growth;Farb;Circulation,2002

5. Endothelial cell recovery between comparator polymer-based drug-eluting stents;Joner;J Am Coll Cardiol,2008

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interventional Approach in Small Vessel, Diffuse, and Tortuous Coronary Artery Disease;Interventional Cardiology;2022-05-06

2. Individual patient data analysis of the BIOFLOW study program comparing safety and efficacy of a bioresorbable polymer sirolimus eluting stent to a durable polymer everolimus eluting stent;Catheterization and Cardiovascular Interventions;2020-09-05

3. Impact of stent diameter on outcomes following percutaneous coronary intervention with second‐generation drug‐eluting stents: Results from a large single‐center registry;Catheterization and Cardiovascular Interventions;2019-09-06

4. Five-year outcomes after first- and second-generation drug-eluting stent implantation in all patients undergoing percutaneous coronary intervention;Journal of Cardiology;2019-08

5. “Bringing on the light” in a complex clinical scenario: Optical coherence tomography–guided discontinuation of antiplatelet therapy in cancer patients with coronary artery disease (PROTECT-OCT registry);American Heart Journal;2017-12